Ratings for IDEXX Laboratories (NASDAQ:IDXX) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview ...
Across the recent three months, 4 analysts have shared their insights on IDEXX Laboratories (NASDAQ:IDXX), expressing a variety of opinions spanning from bullish to bearish. The table below summarizes ...
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It ...
Revenue for Q4 2024 was reported at $954 million, surpassing the estimate of $935 million. Q4 EPS came in at $2.62, exceeding the anticipated $2.40. The Companion Animal Group diagnostics segment ...
Idexx's Q3 adjusted EPS rose 12% to $2.79, beating the $2.68 consensus. Organic revenue grew 6%, driven by Companion Animal and Water segment gains. Live on Wednesday: Historic Summer Setup: 3 "Power ...
We expect our H2 organic revenue growth results to benefit by approximately 0.5% overall from equivalent days effects, reflecting approximately 1% organic growth rate benefits in Q3 with limited ...
IDEXX Labs offers veterinary diagnostic instruments, rapid assay test kits, reference lab services, water quality testing products, and veterinary practice management software. The company generates ...
Wednesday, IDEXX Laboratories Inc (NASDAQ:IDXX) reported first-quarter adjusted EPS of $2.81, up 10% Y/Y, beating the consensus of $2.67. The company reported sales of $964 million, an increase of 7% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results